Eden vs. Sequence by WeightWatchers®: A Side-by-Side Look at GLP-1 Access

What Is Eden?

Eden is a digital health company focused exclusively on improving access to personalized metabolic care. By connecting patients to licensed healthcare providers, Eden makes it easier to evaluate whether GLP-1 therapies, such as semaglutide and tirzepatide, may be a suitable option based on a patient’s health history and clinical markers.

Unlike broader wellness programs, Eden centers its entire platform around metabolic health access. There are no upsells, lifestyle memberships, or brand distractions, just streamlined, evidence-informed access to professional medical care. This appeals particularly to busy women balancing family, career, and personal wellness goals who want expert access without extra noise.

Patients start with a straightforward intake and can often schedule a virtual consultation with a provider within days. Eden’s platform is designed for those who want discreet, physician-focused care that helps them make informed decisions about their body and health.

Eden does not produce, own, or dispense any medications. Instead, it serves as a digital bridge, helping patients navigate access to licensed physicians who make all clinical decisions and work with state-licensed pharmacies for fulfillment.

Learn more about Eden's access process here.

‍

What Is Sequence by WeightWatchers®?

Sequence is a digital health program acquired by WeightWatchers, which blends medical access with behavioral wellness support. Like Eden, it connects patients with licensed providers who evaluate eligibility for GLP-1 treatments. However, the experience is embedded within the broader WW ecosystem.

Along with medical oversight, Sequence members gain access to the full WW app, including food logging, coaching, activity tracking, and habit-building tools. This structure is ideal for users already committed to the WeightWatchers lifestyle or looking for added behavioral support.

However, for those who already manage nutrition and fitness independently or prefer a medical-only experience, this bundled approach may feel overly prescriptive or less relevant to their actual needs.

‍

{{primary-cta}}

‍

Pricing Comparison

Eden Pricing

Eden offers a simple, flat-rate monthly fee that includes provider access, treatment coordination, and support throughout your care journey. There are no hidden fees or required add-ons. If a provider determines a GLP-1 prescription is appropriate, Eden coordinates with a state-licensed compounding pharmacy for fulfillment. Medication cost varies based on dose and availability but is often more affordable than brand-name alternatives.

This transparent pricing structure is ideal for those who want clarity upfront and flexibility in how they manage their care.

Start your intake and get pricing clarity now.

Sequence Pricing

Sequence charges a monthly subscription that includes provider access and WeightWatchers® lifestyle content. Medication costs are not included, and users are expected to navigate pharmacy billing or insurance coverage independently. Over time, the bundled price may be higher for those not actively using WW features.

For patients focused exclusively on GLP-1 access, this model may be less cost-effective compared to Eden’s simplified structure.

‍

Provider Access and Experience

Eden’s Clinical Network

Eden partners with a national network of licensed, experienced physicians who specialize in metabolic health. Patients are matched with an independent provider licensed in their state, who conducts a virtual consultation and, if appropriate, manages treatment follow-up.

Eden emphasizes a science-first, respectful approach tailored to busy women who want medical care that is personal, evidence-informed, and outcome-focused. The experience is structured and clear; patients know exactly what to expect from beginning to end.

Sequence’s Provider Model

Sequence also offers virtual access to licensed providers, who operate within the structure of a lifestyle platform. Appointments are similarly remote, but often layered within a broader ecosystem of coaches and tracking tools.

For some patients, this ecosystem provides additional motivation. For others, particularly those looking for a clean, medical-only pathway, it may feel unnecessary or confusing.

‍

Medication and Pharmacy Coordination

Eden

Eden does not manufacture or dispense medication. If a provider prescribes GLP-1 treatment, Eden facilitates fulfillment through a state-licensed U.S. pharmacy. These pharmacies adhere to strict regulations and provide access to formulations that may be more cost-effective than retail prescriptions.

All medical decisions are made solely by the provider, based on clinical judgment. Eden’s role is to provide access, transparency, and support throughout the process.

GLP-1 receptor agonists, such as semaglutide and tirzepatide, have been studied for their effects on metabolic indicators like blood glucose and body weight. In clinical trials, including the study in The New England Journal of Medicine, participants using semaglutide under medical supervision showed significant changes in metabolic markers. The formulation used in this study was 2.4 mg of semaglutide, administered once weekly via subcutaneous injection. This formulation is the same as what was later approved by the FDA and marketed under the brand name Wegovy® for chronic weight management in adults with obesity or overweight and at least one weight-related condition. 

Additional research published in Nature Medicine in 2022, The SURMOUNT-1 trial, found that participants with obesity who were treated with tirzepatide under medical supervision experienced significant changes in weight and other metabolic markers over a 72-week period. In the SURMOUNT-, participants were treated with tirzepatide, which was later FDA-approved and marketed under the brand name Zepbound® for use in adults with obesity. 

Sequence

Sequence also facilitates prescription fulfillment through pharmacies, though specific details about pharmacy partnerships are not publicly disclosed. Patients may experience variability in pricing or access depending on the provider’s pharmacy selection and their individual insurance coverage.

‍

Which Service Is Right for You?

Choosing between Eden and Sequence depends on your lifestyle, goals, and expectations from a digital care provider:

• Choose Eden if you want direct, clinical access to GLP-1 consultations and treatments, without lifestyle subscriptions or coaching you may not need.
  
• Choose Sequence if you're already a WeightWatchers® user or want to bundle wellness tracking and coaching with your medical access.
  
  

For patients who value clarity, privacy, and efficiency, especially women seeking practical solutions to support how they feel, perform, and present themselves, Eden may offer a more tailored experience.

Begin your care journey with Eden now.

‍

{{primary-cta}}

‍

Conclusion

As GLP-1 medications continue to reshape how patients approach metabolic health, choosing the right access platform becomes essential. Eden and Sequence by WeightWatchers® both provide virtual access to providers, but their approach and focus differ greatly.

Eden is best suited for patients seeking a streamlined, expert-guided experience focused solely on access to care. Sequence may appeal to those who want additional behavior-based tools within a broader lifestyle platform.

Choosing a care partner isn’t just about cost. It’s about confidence. With Eden, patients get fast, discreet access to real medical guidance upon eligibility, without unnecessary subscriptions or lifestyle tie-ins. For women managing households, careers, and personal goals, Eden makes it easier to prioritize your health on your terms.

Start your GLP-1 care journey with Eden today.

‍

Disclaimer

Eden does not practice medicine or manufacture any medication. Eden connects patients with licensed physicians who independently evaluate eligibility for treatment and prescribe medications when appropriate. Eden is not a pharmacy, does not compound medications, and does not make or promote specific drug products. Medications such as semaglutide and tirzepatide are FDA-approved for specific indications. Any reference to metabolic health outcomes must be supported by peer-reviewed evidence, and individual outcomes may vary. Always consult a licensed healthcare provider for medical advice.